An observational study in Stroke, Complication, Stroke, Acute and Stroke Hemorrhagic, sponsored by University of Liege. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-13.
Sponsored by University of Liege · Observational
Retrospective study to assess the incidence of acute complications after thrombectomy for stoke.
Research in the computerized medical file of patients admitted to intensive care unit (ICU) in the last 5 years for a stroke.
Searching for acute complications during the ICU stay. Looking for hemorrhagic, acute renal failure, hemodynamic support, neurologic degradation.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 361 is above the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →University of Liege is the lead sponsor of 242 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Retrospective cohort based on a computer medical record.
Exclusion Criteria:
Patients who have had thrombectomy for acute stroke.
Survival
death during ICU stay
Time frame: day 0 to day 5
hemorrhagic complication
hemorrhagic complication base on CT scan at day 1
Time frame: day 1
Neurological evaluation
Neurological evaluation based on Glasgow coma scale (from 3 pejorative to 15/15 good)
Time frame: day 0 to day 5
Evolution of renal function
Evaluation based on biological analyses : creatinine value based on daily routine blood analysis (in mg/dL).
Time frame: day 0 to day 5
Plan to share: No — There is not a plan to make IPD available.
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Liege